← United KingdomThe Exclusive FeatureShare your journey
The people who built Britain’s companies · November 2026

Home healthcare / health tech

Cera

Cera digitised home care so carers, nurses and AI could flag deterioration early, winning contracts with councils and NHS Integrated Care Systems.

The reason Ben Maruthappu gives for starting Cera is not a market gap. It is a family emergency. One source says his mother fell and fractured her back. Another says he was inspired by trying to coordinate care for a family member. He was a doctor, and he has said little about what that felt like, so the sources do not let me say more.

The documented fact is the contrast. Here was an NHS doctor who knew how care worked from the inside, and still found it hard to arrange for someone he loved. The system was not built to talk to itself.

Debt is a particular vote of confidence: lenders expect a steady, contracted business, and Cera sells largely to councils and the NHS.

He launched Cera in November 2016 with co-founder Marek Sacha, aiming to put technology between a vulnerable person at home and the hospital. The pitch was practical: carers and nurses would visit homes, and software would predict trouble before it landed in an ambulance. The company claims its AI predicts over 80% of falls and 83% of hospitalisations a week ahead, and that hospitalisations fall by up to 70%. These are the company's own numbers, not audited ones.

What almost nobody sees in the funding story is how it was paid for. In January 2025 Cera announced $150m, mostly debt with some equity, led by BDT & MSD Partners and Schroders Capital. That valued it above $1bn and made it a unicorn. Debt is a particular vote of confidence: lenders expect a steady, contracted business, and Cera sells largely to councils and the NHS. The company says it works with more than 150 local governments and two-thirds of NHS Integrated Care Systems.

Scale followed. Cera said it delivers over 60,000 home visits a day, and a data provider listed more than 10,000 carers and nurses in April 2026. Maruthappu has said the company is getting to profitability, though no audited profit figure appears in what I could read.

The price of this model is not dramatic, but it is real. Home care is a regulated, low-margin trade where staff retention and council budgets decide the year. Cera has had to grow into Germany while still proving its numbers.

The lesson is almost banal. The founders of the large things often begin with a phone call to arrange something for someone they love, and a system that made that call hard.

The Chronology year by year

  1. 2016
    • launched (Nov)
  2. 2025
    • $150m raise and unicorn status; German expansion
  3. 2026
    • Caplight lists over 10,000 carers and about 2.5m visits per month (Apr 2026)

The Money Trail how it was funded

  1. GBP27m seed extension (Private Equity Wire headline)
  2. Jan 2025 $150m mostly debt with some equity (BDT & MSD Partners, Schroders Capital) at over $1bn valuation

Principal backers: BDT & MSD Partners, Schroders Capital, Earlymarket, Guinness Ventures, Robin Klein

The Close Calls what nearly broke it

  • Scaling regulated home care with stretched NHS funding; claims about AI and profitability rest on company statements

In Their Own Words from the record

Spotted something wrong? Send a correction.

Startup Talk · Preview edition · Figures are from public sources and may be out of date
About · Contact · Terms · Privacy · Badge · Share your journey